• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM
Click for more information
4.55% 2.1¢

CHIMERIC THERAPEUTICS LIMITED

Market Cap $17.98M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase I clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of four NK and CAR NK assets with plans for Phase I clinical trials in solid tumors and blood cancers.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM
Ann: FDA clearance of IND for CHM 2101
2
17/05/24 74 21K
17/05/24 Last post  mrdingo Comments Created with Sketch.  74  Views Created with Sketch.  21K 
CHM
Ann: Notice of Extraordinary General Meeting/Proxy Form
2
17/05/24 93 20K
17/05/24 Last post  Steini Comments Created with Sketch.  93  Views Created with Sketch.  20K 
CHM
Ann: CHM CORE-NK vactosertib Phase 1b study re-opens enrolment 		17/05/24 16 2.9K
Metals & Mining SECTOR NEWS

Meet Sun Silver (ASX:SS1) - ASX's newest silver player based in Nevada, USA.

Read More   right-arrow Created with Sketch.
SS1
17 May 2024
SUN SILVER LIMITED
17/05/24 Last post  Steini Comments Created with Sketch.  16  Views Created with Sketch.  2.9K 
CHM
Ann: 1st patient dosed in CHM 0201 Vactosertib trial 		16/05/24 15 7.2K
16/05/24 Last post  ma420 Comments Created with Sketch.  15  Views Created with Sketch.  7.2K 
CHM
Ann: Notification regarding unquoted securities - CHM 		13/05/24 0 315
13/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  315 
CHM
Charting Only
6 7 8
09/05/24 428 149K
09/05/24 Last post  dalts66 Comments Created with Sketch.  428  Views Created with Sketch.  149K 
CHM
accumulate 		08/05/24 6 2.3K
08/05/24 Last post  NZ Trader Comments Created with Sketch.  6  Views Created with Sketch.  2.3K 
CHM
Ann: Dr Rebecca McQualter appointed COO 		08/05/24 14 5.2K
08/05/24 Last post  pinch2020 Comments Created with Sketch.  14  Views Created with Sketch.  5.2K 

See All Discussions arrow Created with Sketch.

Timeline

CHM CORE-NK vactosertib Phase 1b study re-opens enrolment
16 May 09:27
 
Notification regarding unquoted securities - CHM
13 May 17:09
 
Notice of Extraordinary General Meeting/Proxy Form
13 May 09:01
 
Notice under section 708A
02 May 17:39
 
Application for quotation of securities - CHM
02 May 17:34
 
Dr Rebecca McQualter appointed COO
02 May 09:59
 
View More arrow Created with Sketch.

Featured News

RCE Recce Pharma heading closer to full efficacy data for flagship R327
right-arrow Created with Sketch.
NEWS 'Future in Aussie' Budget boost could turn IGO into a Cinderella stock
right-arrow Created with Sketch.
SBW Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management
right-arrow Created with Sketch.
TLG Talga ups graphite exploration target as crit minerals stay in focus
right-arrow Created with Sketch.
ENR Encounter pulls a rabbit out of the hat chasing copper at Sandover
right-arrow Created with Sketch.
SBW The home PC changed retail stores forever. Shekel Brainweigh can do it again
right-arrow Created with Sketch.
(20min delay)
Last
2.1¢ 		Change
-0.001(4.55%) 		Mkt cap ! $17.98M
Open High Low Value Volume
2.2¢ 2.2¢ 2.1¢ $28.15K 1.320M

Buyers (Bids)

No. Vol. Price($)
6 938219 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 116461 2
View Market Depth
Last trade - 15.50pm 17/05/2024 (20 minute delay) ?
Last
2.2¢ 		  Change
-0.001 ( 2.22 %)
Open High Low Volume
2.2¢ 2.2¢ 2.1¢ 798132
Last updated 14.32pm 17/05/2024 ?
CHM (ASX) Chart

Top Stories

Greentech and Anax team up to put Whim Creek copper hub on steroids

GreenTech Metals and Anax Metals are set to sign a memorandum of understanding to strategise processing and development of key copper assets.
Encounter pulls a rabbit out of the hat chasing copper at Sandover Enclunter Resources Ltd has found high grade copper through drilling at its Sandover project in the Northern Territory.
Pegmatites under glacial cover excite Cygnus in Quebec Till sampling at the Ausclair project in Canada has shown potential for multiple pegmatites to be found under cover.
Tambourah gets state govt grant for drilling at namesake gold project in WA Tambourah Metals Ltd is set to prioritise diamond drilling at flagship gold project in WA after the state government awarded a grant.
Market Update: ASX dips with only materials afloat The ASX is down nearly half a per cent - on par with future's predictions - with every sector, side from materials, in the red.

Featured News

MTL After long delays, Mantle Minerals kicks off drillrun for gold at Mt Berghaus
right-arrow Created with Sketch.
RCE Recce Pharma heading closer to full efficacy data for flagship R327
right-arrow Created with Sketch.
AT1 This stock provides Oz's only HIV self-test kit – and it's bullish on the budget
right-arrow Created with Sketch.
FRE Firebrick Pharma sees substantial holder up stake to 12% in placement
right-arrow Created with Sketch.
NEWS Market Open: Index to edge back to end the week
right-arrow Created with Sketch.
NEWS 'Future in Aussie' Budget boost could turn IGO into a Cinderella stock
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.